Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-0804
Full Text
Open PDFAbstract
Available in full text
Date
November 15, 2008
Authors
Publisher
American Association for Cancer Research (AACR)